Posted by Michael Wonder on 14 Jul 2021
Kesimpta (ofatumumab) approved for relapsing remitting MS in Scotland
12 July 2021 - The SMC has recommended that Kesimpta can be prescribed for people with relapsing remitting multiple sclerosis who are having relapses or have MRI evidence of multiple sclerosis activity.
NICE recommended Kesimpta for the NHS in England and Wales earlier this year.
